BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30488259)

  • 1. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
    Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
    Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).
    Lavín-Alconero L; Fernández-Lanas T; Iruzubieta-Coz P; Arias-Loste MT; Rodriguez-Duque JC; Rivas C; Cagigal ML; Montalbán C; Useros AL; Álvarez-Cancelo A; García-Saiz M; Crespo-García J
    Trials; 2021 Oct; 22(1):756. PubMed ID: 34717726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis.
    Cabré N; Luciano-Mateo F; Baiges-Gayà G; Fernández-Arroyo S; Rodríguez-Tomàs E; Hernández-Aguilera A; París M; Sabench F; Del Castillo D; López-Miranda J; Menéndez JA; Camps J; Joven J
    Aliment Pharmacol Ther; 2020 Feb; 51(3):374-387. PubMed ID: 31825539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
    Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
    Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity.
    Anjani K; Lhomme M; Sokolovska N; Poitou C; Aron-Wisnewsky J; Bouillot JL; Lesnik P; Bedossa P; Kontush A; Clement K; Dugail I; Tordjman J
    J Hepatol; 2015 Apr; 62(4):905-12. PubMed ID: 25450212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.
    Jung Y; Lee MK; Puri P; Koo BK; Joo SK; Jang SY; Lee DH; Jung YJ; Kim BG; Lee KL; Park TS; Kang KT; Ryu DH; Kang SW; Kim D; Oh S; Kim W; Hwang GS
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1603-1614. PubMed ID: 32892365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort.
    Koh ZJ; Salgaonkar HP; Lee WJJ; Kim GW; Tan CH; Cheng A; Lomanto D; So JBY; Dan YY; Shabbir A
    Obes Surg; 2019 Mar; 29(3):862-868. PubMed ID: 30515622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
    Verrastro O; Panunzi S; Castagneto-Gissey L; De Gaetano A; Lembo E; Capristo E; Guidone C; Angelini G; Pennestrì F; Sessa L; Vecchio FM; Riccardi L; Zocco MA; Boskoski I; Casella-Mariolo JR; Marini P; Pompili M; Casella G; Fiori E; Rubino F; Bornstein SR; Raffaelli M; Mingrone G
    Lancet; 2023 May; 401(10390):1786-1797. PubMed ID: 37088093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity.
    Nikai H; Ishida K; Umemura A; Baba S; Nitta H; Sugai T; Sasaki A
    Obes Surg; 2020 Jul; 30(7):2579-2587. PubMed ID: 32124215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients.
    Murakami E; Nakahara T; Hiramatsu A; Morio K; Fujino H; Yamauchi M; Kawaoka T; Tsuge M; Imamura M; Aikata H; Fudeyasu K; Nakashima Y; Iwaki D; Jodai D; Ohigashi T; Nishimura Y; Minamoto Y; Nagao A; Yoneda M; Saeki Y; Tanabe K; Ohdan H; Chayama K
    Medicine (Baltimore); 2021 Jul; 100(26):e26436. PubMed ID: 34190166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.
    Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M
    Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS).
    Motamedi MAK; Khalaj A; Mahdavi M; Valizadeh M; Hosseinpanah F; Barzin M
    Obes Surg; 2019 Feb; 29(2):511-518. PubMed ID: 30298459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of restrictive and malabsorptive bariatric surgery procedures on the serum lipidome in obese subjects.
    Ramos-Molina B; Castellano-Castillo D; Alcaide-Torres J; Pastor Ó; de Luna Díaz R; Salas-Salvadó J; López-Moreno J; Fernández-García JC; Macías-González M; Cardona F; Tinahones FJ
    J Clin Lipidol; 2018; 12(6):1502-1512. PubMed ID: 30143432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.